Cutaneous T-cell lymphoma.
OBJECTIVE
To review recent information on the epidemiology, etiology, clinical presentation, staging, treatment approaches, and nursing management of CTCL.


METHODS
Research and review articles and textbooks.


CONCLUSIONS
Identifying the etiology and finding a cure for cutaneous T-cell lymphoma is promising as our knowledge and understanding of the T-cell biology evolves, creating more options for innovative therapies or treatment modalities.


CONCLUSIONS
It is essential for the oncology nurse to understand the disease process, treatment modalities, and side effect profiles to provide astute nursing assessment, establishment of treatment goals, management of cutaneous symptoms, treatment of side effects, and pain control while preventing infection and providing psychological/social support throughout the course of the disease.
Gemmill
Robin
R
City of Hope National Medical Center, Duarte, CA, USA. rgemmill@coh.org
D000970:Antineoplastic Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy / Q000451:nursing / Q000473:pathology; D009182:Mycosis Fungoides / Q000473:pathology; D009367:Neoplasm Staging; D010789:Phototherapy; D012751:Sezary Syndrome / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000473:pathology
D000970:Antineoplastic Agents